DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 02 · Volume 41 · May 2021 DOI: 10.1055/s-011-51103

Review Article

  • 109
    Marcellin, Fabienne; Jaquet, Antoine; Lazarus, Jeffrey V.; Molina, Patricia; Carrieri, Patrizia:

    Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play

  • 117
  • 128
    Dunn, Michael A.; Kappus, Matthew R.; Bloomer, Pamela M.; Duarte-Rojo, Andres; Josbeno, Deborah A.; Jakicic, John M.:

    Wearables, Physical Activity, and Exercise Testing in Liver Disease

  • 136
    Uson Junior, Pedro Luiz Serrano; Nagalo, Bolni Marius; Ahn, Daniel H.; Bekaii-Saab, Tanios; Borad, Mitesh J.:

    Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?

  • 142
  • 150
    Kaufmann, Benedikt; Reca, Agustina; Kim, Andrea D.; Feldstein, Ariel E.:

    Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications

  • 163
    Ortiz, Vivian; Ellenberg, Susan S.; Weinberg, Ethan M.:

    Blinding in Clinical Trials for Chronic Liver Diseases

  • 172
    Moeckli, Beat; Majno, Pietro; Orci, Lorenzo A.; Peloso, Andrea; Toso, Christian:

    Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective

  • 182
  • 191
  • 206
    Soroka, Carol J.; Roberts, Scott J.; Boyer, James L.; Assis, David N.:

    Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine

  • 213
    Haep, Nils; Florentino, Rodrigo M.; Squires, James E.; Bell, Aaron; Soto-Gutierrez, Alejandro:

    The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone